论文部分内容阅读
人绝经期促性腺激素(hMG)促卵泡发育被推荐作为许多不孕的治疗方法。尽管阴道超声等技术上的进步改善了对卵巢反应性的监测,但多数治疗周期仍不受孕,一个可能的原因是卵泡发育及排卵与子宫内膜的发育不同步。为评价超声测量围排卵期子宫内膜厚度预测hMG刺激周期妊娠的能力,作者对112例共292个刺激周期(仅用hMG)的有关数据进行了回顾性分析。 从月经周期第3d始以hMG促卵泡发育,初始剂量从75～225IU/d。4d后测血雌
Human menopausal gonadotropin (hMG) follicular development is recommended as a treatment for many infertility. Although advances in techniques such as vaginal ultrasound improve the monitoring of ovarian response, the majority of treatment cycles are still not fertilized. One possible reason is that follicular development and ovulation do not synchronize with endometrial development. To evaluate the ability of hMG to stimulate periodic pregnancies by measuring peri-ovulation endometrial thickness using echocardiography, we retrospectively analyzed data from 112 patients with a total of 292 stimulation cycles (hMG only). From the first three days of the menstrual cycle to hMG follicular development, the initial dose from 75 ~ 225IU / d. Blood test after 4d female